Phospholipase D (PLD) is a key player in the modulation of multiple aspects of cell physiology and has been proposed as a therapeutic target for Alzheimer’s disease (AD). This evidence concerns the gene GPLD1 and early-onset autosomal dominant Alzheimer disease.